Wednesday, October 19, 2016 2:42:30 PM
- Keytruda combo data will be released on November 11 at the SITC
- Clinical and regulatory pathways to be discussed on the Analyst day on Nov 17
- If the data is good, they could approach Merck or Roche for combinations (not my opinion; this was what PD said)
- working with FDA on clinical and reg pathway
- Regarding the JCI peer-reviewed article - "Merck agreed to allow us to use a predictive assay..."
(No hesitation whatsoever to call Merck a collaborator at another instance during the call)
- Multigene candidate can target 4-6 genes; so far such efforts from others have seen toxicity; to be in the clinics in 2018
- $28M in cash & cash equivalents since last filings; no plan to raise capital at this time
I thought it was a good call. Feeling more and more confident about the upcoming data release. More was discussed but I didn't jot down everything. Perhaps the webcast will be available to listen to again or a transcript will be available on SeekingAlpha in the coming days. GL to all invested.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM